QuantifiCare achieves major favorable UPC decision with multi-country injunction against Canfield
QuantifiCare Focuses on Aesthetics By Launching Quartier Latin
QuantifiCare and Legit.Health Launch the First AI-Powered Dermatology Imaging Platform for Clinical Trials
Major Legal Victory for QuantifiCare: Düsseldorf Court Confirms Patent Infringement by Canfield’s Vectra H2 System
A Legacy of Excellence: QuantifiCare Wins “Best Aesthetic Device” for the 6th Time with DermaViz UV
QuantifiCare and Nikon: Building the Future of Imaging Technology Together
Revolutionizing Medical Imaging: QuantifiCare partners with Inria, i3S (CNRS) and Hosteur to Advance AI innovations to Improve Health Outcomes
QuantifiCare v. Canfield Scientific: German Federal Supreme Court Upholds QuantifiCare’s LifeViz® Infinity Patent
QuantifiCare Featured in Prime Journal: Showcasing Innovation in Aesthetic Technology
LifeViz® Micro Featured in Groundbreaking Clinical Study on Sleep Wrinkles Reduction
LifeViz® Mini Pro Awarded Best Aesthetic Device 2024
LifeViz Infinity Pro Awarded Best Aesthetic Device
QuantifiCare Partners with FotoFinder to Bring Mobile Dermoscopy to Clinical Trials
QuantifiCare is now in Denmark!
COVID-19 New FDA Guidance: Mobile Imaging For Clinical Trials
QuantifiCare becomes three-time winner of Best Aesthetic Device: LifeViz® Micro
QuantifiCare receives fundraising from Venture Fund
LifeViz® Infinity: Winner of Best Aesthetic Device award
LifeViz® Mini: Winner of Best Aesthetic Device award
